![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-218x150.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
Macular Degeneration
SCOTS2 Eye Treatment
MD Stem Cells treats Dry AMD -shows imaginative and prescient restoration & enchancment now doable
— Dr. Levy
USA, September 23, 2022 /EINPresswire.com/ — Age Related Macular Degeneration (AMD), a illness of the retina, can result in everlasting imaginative and prescient loss and blindness. An astounding 11 million individuals at the moment have AMD within the United States and it’s anticipated to impression over 280 million individuals worldwide within the subsequent 20 years.
WHAT JUST HAPPENED:
A brand new autologous stem cell method, developed by MD Stem Cells, has now been proven to be extremely efficient for sufferers with dry AMD. Using the affected person’s personal stem cells in a prescribed vogue, the MD Stem Cells therapy demonstrated a exceptional profit to sufferers, with 63% of handled eyes exhibiting important enchancment in imaginative and prescient and a remaining 34% of handled eyes exhibiting imaginative and prescient stability. In complete, a real profit to 97% of dry AMD eyes. Results have been discovered to be statistically significant- the gold commonplace for confirming these outcomes are correct and this particular therapy is answerable for the profit reported. Results have been revealed within the Medicines Journal- a extremely regarded worldwide medical journal. The article is titled Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells within the Treatment of Age-Related Macular Degeneration
WHY THIS IS IMPORTANT:
What makes the MD Stem Cells’ therapy significantly vital is that no medicine has beforehand been discovered to deal with dry AMD. Taking a formulation of sure nutritional vitamins and minerals known as AREDS2 could cut back the danger of bleeding or moist AMD, however solely through the intermediate type of dry AMD. Unfortunately AREDS2, nutritional vitamins or food plan haven’t been proven to enhance or stabilize affected person imaginative and prescient. The MD Stem Cell SCOTS therapy is the primary method to have confirmed profit to imaginative and prescient.
DETAILS OF RESULTS:
The key factors of the MD Stem Cell report have been that 63% of dry AMD eyes handled and monitored for not less than one yr had imaginative and prescient enchancment. Improvements in visible acuity averaged 27.6% and ranged as much as 44.6% on a scientific imaginative and prescient scale known as LogMAR. An extra 34% of eyes remained secure for the comply with up period- which means no extra imaginative and prescient loss was present in these eyes that had been dropping imaginative and prescient beforehand. The findings have been extremely statistically important with p < 0.001, which means that the outcomes overwhelmingly met the medical commonplace of certainty that this particular stem cell therapy know-how was answerable for the enhancements seen.
THE TREATMENT:
The Stem Cell Treatment Ophthalmology Study II – abbreviated SCOTS2, makes use of the affected person’s personal bone marrow stem cells (BMSC) positioned in two particular areas of the orbit, adopted by intravenous. The examine is Institutional Board Approved and National Institutes of Health registered on www.clinicaltrials.gov NCT 03011541. All sufferers obtain lively stem cell therapy; there isn’t any placebo or sham.
OTHER EYE DISEASES THIS CAN HELP:
The physicians concerned with MD Stem Cells now have 14 world class medical and scientific publications reporting their optimistic ends in various totally different retinal and optic nerve illnesses. Their experiences encompasses different extra eye situations, a lot of which have proven enchancment. These embrace different kinds of retinal illnesses akin to Stargardt, Retinitis Pigmentosa, Usher, Stargardts, Cone-Rod, Rod-Cone, Cone dystrophy, Bests dystrophy, non-perfusion retinopathy, retinal harm, retinal irritation akin to POHS or choroiditis, sure diabetic retinopathies and sure publish Retinal Detachment imaginative and prescient loss. Quite a lot of optic nerve situations have additionally responded together with Glaucoma, NAION, LHON, ADOA, optic nerve ischemia/ neuropathy/ optic neuritis/optic atrophy/ and optic nerve compression. This is vastly greater than another stem cell analysis group working with eye illness and must be reassuring to sufferers and well being care suppliers searching for therapy choices.
WHAT TO REMEMBER:
The statistics and affirmation of profit solely apply to MD Stem Cells particular method to stem cell therapy of dry AMD.
Dr. Levy concludes: “Our analysis has proven that sufferers with dry AMD accepted and selecting to take part within the SCOTS2 have a major chance of both enhancing or stabilizing their imaginative and prescient. MD Stem Cells has labored to realize the most secure, only method to dry AMD- with gratifying success.”
HOW TO GET MORE INFORMATION:
Patients could greatest obtain details about taking part in SCOTS2 by emailing Dr. Levy at [email protected] with their title, cellphone, electronic mail tackle and temporary historical past of their illness. They may additionally use the contact us web page on www.mdstemcells.com or attain him at 203-423-9494. The Stem Cell Ophthalmology Study 2 is enrolling sufferers with totally different retina and optic nerve illnesses.
Treatment is accessible in Florida, USA and Dubai, UAE.
MD Stem Cells has no grant help and isn’t a pharmaceutical firm; it is a affected person sponsored research and the sufferers pay for each therapy and journey.
Steven Levy
MD Stem Cells
+1 203-423-9494
electronic mail us right here
